Molecular biology of autoinflammatory diseases

Abstract The long battle between humans and various physical, chemical, and biological insults that cause cell injury (e.g., products of tissue damage, metabolites, and/or infections) have led to the evolution of various adaptive responses. These responses are triggered by recognition of damage-asso...

Full description

Bibliographic Details
Main Authors: Junya Masumoto, Wei Zhou, Shinnosuke Morikawa, Sho Hosokawa, Haruka Taguchi, Toshihiro Yamamoto, Mie Kurata, Naoe Kaneko
Format: Article
Language:English
Published: BMC 2021-10-01
Series:Inflammation and Regeneration
Subjects:
Online Access:https://doi.org/10.1186/s41232-021-00181-8
_version_ 1818724713784934400
author Junya Masumoto
Wei Zhou
Shinnosuke Morikawa
Sho Hosokawa
Haruka Taguchi
Toshihiro Yamamoto
Mie Kurata
Naoe Kaneko
author_facet Junya Masumoto
Wei Zhou
Shinnosuke Morikawa
Sho Hosokawa
Haruka Taguchi
Toshihiro Yamamoto
Mie Kurata
Naoe Kaneko
author_sort Junya Masumoto
collection DOAJ
description Abstract The long battle between humans and various physical, chemical, and biological insults that cause cell injury (e.g., products of tissue damage, metabolites, and/or infections) have led to the evolution of various adaptive responses. These responses are triggered by recognition of damage-associated molecular patterns (DAMPs) and/or pathogen-associated molecular patterns (PAMPs), usually by cells of the innate immune system. DAMPs and PAMPs are recognized by pattern recognition receptors (PRRs) expressed by innate immune cells; this recognition triggers inflammation. Autoinflammatory diseases are strongly associated with dysregulation of PRR interactomes, which include inflammasomes, NF-κB-activating signalosomes, type I interferon-inducing signalosomes, and immuno-proteasome; disruptions of regulation of these interactomes leads to inflammasomopathies, relopathies, interferonopathies, and proteasome-associated autoinflammatory syndromes, respectively. In this review, we discuss the currently accepted molecular mechanisms underlying several autoinflammatory diseases.
first_indexed 2024-12-17T21:30:48Z
format Article
id doaj.art-70d7aff5e3b0451ab4273d60ce5b8351
institution Directory Open Access Journal
issn 1880-8190
language English
last_indexed 2024-12-17T21:30:48Z
publishDate 2021-10-01
publisher BMC
record_format Article
series Inflammation and Regeneration
spelling doaj.art-70d7aff5e3b0451ab4273d60ce5b83512022-12-21T21:31:53ZengBMCInflammation and Regeneration1880-81902021-10-0141112610.1186/s41232-021-00181-8Molecular biology of autoinflammatory diseasesJunya Masumoto0Wei Zhou1Shinnosuke Morikawa2Sho Hosokawa3Haruka Taguchi4Toshihiro Yamamoto5Mie Kurata6Naoe Kaneko7Department of Pathology, Ehime University Graduate School of Medicine and Proteo-Science CenterDepartment of Pathology, Ehime University Graduate School of Medicine and Proteo-Science CenterDepartment of Pathology, Ehime University Graduate School of Medicine and Proteo-Science CenterDepartment of Pathology, Ehime University Graduate School of Medicine and Proteo-Science CenterDepartment of Pathology, Ehime University Graduate School of Medicine and Proteo-Science CenterDepartment of Pathology, Ehime University Graduate School of Medicine and Proteo-Science CenterDepartment of Pathology, Ehime University Graduate School of Medicine and Proteo-Science CenterDepartment of Pathology, Ehime University Graduate School of Medicine and Proteo-Science CenterAbstract The long battle between humans and various physical, chemical, and biological insults that cause cell injury (e.g., products of tissue damage, metabolites, and/or infections) have led to the evolution of various adaptive responses. These responses are triggered by recognition of damage-associated molecular patterns (DAMPs) and/or pathogen-associated molecular patterns (PAMPs), usually by cells of the innate immune system. DAMPs and PAMPs are recognized by pattern recognition receptors (PRRs) expressed by innate immune cells; this recognition triggers inflammation. Autoinflammatory diseases are strongly associated with dysregulation of PRR interactomes, which include inflammasomes, NF-κB-activating signalosomes, type I interferon-inducing signalosomes, and immuno-proteasome; disruptions of regulation of these interactomes leads to inflammasomopathies, relopathies, interferonopathies, and proteasome-associated autoinflammatory syndromes, respectively. In this review, we discuss the currently accepted molecular mechanisms underlying several autoinflammatory diseases.https://doi.org/10.1186/s41232-021-00181-8Interleukin-1NF-κBType I interferonAutoinflammatory diseases
spellingShingle Junya Masumoto
Wei Zhou
Shinnosuke Morikawa
Sho Hosokawa
Haruka Taguchi
Toshihiro Yamamoto
Mie Kurata
Naoe Kaneko
Molecular biology of autoinflammatory diseases
Inflammation and Regeneration
Interleukin-1
NF-κB
Type I interferon
Autoinflammatory diseases
title Molecular biology of autoinflammatory diseases
title_full Molecular biology of autoinflammatory diseases
title_fullStr Molecular biology of autoinflammatory diseases
title_full_unstemmed Molecular biology of autoinflammatory diseases
title_short Molecular biology of autoinflammatory diseases
title_sort molecular biology of autoinflammatory diseases
topic Interleukin-1
NF-κB
Type I interferon
Autoinflammatory diseases
url https://doi.org/10.1186/s41232-021-00181-8
work_keys_str_mv AT junyamasumoto molecularbiologyofautoinflammatorydiseases
AT weizhou molecularbiologyofautoinflammatorydiseases
AT shinnosukemorikawa molecularbiologyofautoinflammatorydiseases
AT shohosokawa molecularbiologyofautoinflammatorydiseases
AT harukataguchi molecularbiologyofautoinflammatorydiseases
AT toshihiroyamamoto molecularbiologyofautoinflammatorydiseases
AT miekurata molecularbiologyofautoinflammatorydiseases
AT naoekaneko molecularbiologyofautoinflammatorydiseases